02_CD GlaxoSmithKline_NNP Financial_NNP summary_NN 2003_CD 2004_CD restated_VBN Growth_NN Statutory_JJ results_NNS m_VBP m_FW CER_CD %_NN %_NN Turnover_NN 20,359_CD 21,441_CD 1_CD 5_CD Trading_NN profit_NN 6,150_CD 6,509_CD 5_CD 6_CD profit_NN before_IN taxation_NN 6,119_CD 6,313_CD 8_CD 3_CD Earnings_NNS Net_JJ income_NN 4,302_CD 4,478_CD 7_CD 4_CD Basic_JJ earnings_NNS per_IN share_NN 75.0_CD p_NN 77.1_CD p_NN 8_CD 3_CD Dividends_NNS per_IN share_NN 42.0_CD p_VBP 41.0_CD p_JJ Merger_NNP ,_, restructuring_NN and_CC disposal_NN of_IN subsidiaries_NNS Trading_NN profit_NN 395_CD profit_NN before_IN taxation_NN 390_CD Earnings_NNS Net_JJ income_NN 281_CD Earnings_NNS per_IN share_NN 4.9_CD p_NNP Business_NNP performance_NN Turnover_NN 20,359_CD 21,441_CD 1_CD 5_CD Trading_NN profit_NN 6,150_CD 6,904_CD 1_CD 11_CD profit_NN before_IN taxation_NN 6,119_CD 6,703_CD 2_CD 9_CD Adjusted_VBN earnings_NNS Net_JJ income_NN 4,302_CD 4,759_CD 1_CD 10_CD Adjusted_VBN earnings_NNS per_IN share_NN 75.0_CD p_NN 82.0_CD p_NN 2_CD 9_CD The_DT Group_NNP ,_, as_IN a_DT multinational_JJ business_NN ,_, operates_VBZ in_IN many_JJ countries_NNS and_CC earns_VBZ revenues_NNS and_CC incurs_VBZ costs_NNS in_IN many_JJ currencies_NNS ._.
The_DT results_NNS of_IN the_DT Group_NNP ,_, as_IN reported_VBN in_IN sterling_NN ,_, are_VBP therefore_RB affected_VBN by_IN movements_NNS in_IN exchange_NN rates_NNS between_IN sterling_NN and_CC overseas_JJ currencies_NNS ._.
Average_JJ exchange_NN rates_NNS prevailing_VBG during_IN the_DT period_NN are_VBP used_VBN to_TO translate_VB the_DT results_NNS and_CC cash_NN ows_NNS of_IN overseas_JJ subsidiary_NN and_CC associated_VBN undertakings_NNS and_CC joint_JJ ventures_NNS into_IN sterling_NN ._.
Period_NN end_NN rates_NNS are_VBP used_VBN to_TO translate_VB the_DT net_JJ assets_NNS of_IN those_DT undertakings_NNS ._.
The_DT currencies_NNS which_WDT most_RBS inuence_JJ these_DT translations_NNS are_VBP the_DT US_NNP dollar_NN ,_, the_DT Euro_NNP and_CC the_DT Japanese_JJ Yen_NN ._.
In_IN order_NN to_TO illustrate_VB underlying_VBG performance_NN ,_, it_PRP is_VBZ the_DT Groups_NNS practice_NN to_TO discuss_VB its_PRP$ results_NNS in_IN terms_NNS of_IN constant_JJ exchange_NN rate_NN CER_NNP growth_NN ._.
This_DT represents_VBZ growth_NN calculated_VBN as_IN if_IN the_DT exchange_NN rates_NNS used_VBN to_TO determine_VB the_DT results_NNS of_IN overseas_JJ companies_NNS in_IN sterling_NN had_VBD remained_VBN unchanged_JJ from_IN those_DT used_VBN in_IN the_DT previous_JJ year_NN ._.
CER_CD %_NN represents_VBZ growth_NN at_IN constant_JJ exchange_NN rates_NNS ._.
%_NN represents_VBZ growth_NN at_IN actual_JJ exchange_NN rates_NNS ._.
During_IN the_DT years_NNS 2000_CD to_TO 2003_CD ,_, business_NN performance_NN was_VBD the_DT primary_JJ performance_NN measure_NN used_VBN by_IN management_NN and_CC was_VBD presented_VBN after_IN excluding_VBG merger_NN items_NNS ,_, integration_NN and_CC restructuring_NN costs_NNS and_CC disposals_NNS of_IN businesses_NNS ._.
Management_NNP believes_VBZ that_IN exclusion_NN of_IN these_DT items_NNS provides_VBZ a_DT better_JJR comparison_NN of_IN the_DT way_NN in_IN which_WDT the_DT business_NN was_VBD managed_VBN and_CC gives_VBZ an_DT indication_NN of_IN the_DT performance_NN of_IN the_DT Group_NNP in_IN terms_NNS of_IN those_DT elements_NNS of_IN revenue_NN and_CC expenditure_NN which_WDT local_JJ management_NN was_VBD able_JJ to_TO inuence_NN ._.
For_IN 2004_CD ,_, with_IN the_DT completion_NN of_IN these_DT programs_NNS ,_, the_DT Group_NNP is_VBZ reporting_VBG results_NNS on_IN a_DT statutory_JJ basis_NN only_RB ._.
Growth_NN rates_NNS are_VBP presented_VBN comparing_VBG 2004_CD results_NNS both_DT with_IN 2003_CD business_NN performance_NN results_NNS and_CC 2003_CD statutory_JJ results_NNS ._.
Management_NNP considers_VBZ that_IN the_DT comparison_NN of_IN 2004_CD statutory_JJ results_NNS with_IN 2003_CD business_NN performance_NN results_NNS gives_VBZ the_DT most_RBS appropriate_JJ indication_NN of_IN the_DT Groups_NNS performance_NN for_IN the_DT period_NN under_IN review_NN and_CC therefore_RB commentaries_NNS are_VBP presented_VBN on_IN this_DT basis_NN unless_IN otherwise_RB stated_VBN ._.
Cautionary_JJ statement_NN regarding_VBG forward-looking_JJ statements_NNS The_DT Group_NNP 's_POS reports_NNS led_VBD with_IN or_CC furnished_VBN to_TO the_DT US_NNP Securities_NNPS and_CC Exchange_NNP Commission_NNP SEC_NNP ,_, including_VBG this_DT document_NN and_CC written_VBN information_NN released_VBN ,_, or_CC oral_JJ statements_NNS made_VBN ,_, to_TO the_DT public_NN in_IN the_DT future_NN by_IN or_CC on_IN behalf_NN of_IN the_DT Group_NNP ,_, may_MD contain_VB forward-looking_JJ statements_NNS ._.
Forward-looking_VBG statements_NNS give_VBP the_DT Group_NNP 's_POS current_JJ expectations_NNS or_CC forecasts_NNS of_IN future_JJ events_NNS ._.
An_DT investor_NN can_MD identify_VB these_DT statements_NNS by_IN the_DT fact_NN that_IN they_PRP do_VBP not_RB relate_VB strictly_RB to_TO historical_JJ or_CC current_JJ facts_NNS ._.
They_PRP use_VBP words_NNS such_JJ as_IN anticipate_VBP ,_, estimate_VBP ,_, expect_VBP ,_, intend_VBP ,_, will_MD ,_, project_NN ,_, plan_NN ,_, believe_VB and_CC other_JJ words_NNS and_CC terms_NNS of_IN similar_JJ meaning_NN in_IN connection_NN with_IN any_DT discussion_NN of_IN future_JJ operating_NN or_CC financial_JJ performance_NN ._.
In_IN particular_JJ ,_, these_DT include_VBP statements_NNS relating_VBG to_TO future_JJ actions_NNS ,_, prospective_JJ products_NNS or_CC product_NN approvals_NNS ,_, future_JJ performance_NN or_CC results_NNS of_IN current_JJ and_CC anticipated_JJ products_NNS ,_, sales_NNS efforts_NNS ,_, expenses_NNS ,_, the_DT outcome_NN of_IN contingencies_NNS such_JJ as_IN legal_JJ proceedings_NNS ,_, and_CC financial_JJ results_NNS ._.
The_DT Group_NNP undertakes_VBZ no_DT obligation_NN to_TO update_VB any_DT forward-looking_JJ statements_NNS ,_, whether_IN as_IN a_DT result_NN of_IN new_JJ information_NN ,_, future_JJ events_NNS or_CC otherwise_RB ._.
Forward-looking_VBG statements_NNS involve_VBP inherent_JJ risks_NNS and_CC uncertainties_NNS ._.
The_DT Group_NNP cautions_VBZ investors_NNS that_IN a_DT number_NN of_IN important_JJ factors_NNS including_VBG those_DT in_IN this_DT document_NN could_MD cause_VB actual_JJ results_NNS to_TO differ_VB materially_RB from_IN those_DT contained_VBN in_IN any_DT forward-looking_JJ statement_NN ._.
Such_JJ factors_NNS include_VBP ,_, but_CC are_VBP not_RB limited_VBN to_TO ,_, those_DT discussed_VBN under_IN Risk_NNP factors_NNS on_IN pages_NNS 76_CD to_TO 78_CD of_IN this_DT Annual_JJ Report_NNP ._.
